These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35942654)

  • 1. Increased histologic inflammation is an independent risk factor for nonconventional dysplasia in ulcerative colitis.
    Nguyen ED; Wang D; Lauwers GY; Choi WT
    Histopathology; 2022 Nov; 81(5):644-652. PubMed ID: 35942654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Zhang R; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Sep; 48(9):1154-1163. PubMed ID: 38809303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development of Serrated Epithelial Change in Ulcerative Colitis is not Significantly Associated With Increased Histologic Inflammation.
    Bahceci D; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; 48(6):719-725. PubMed ID: 38584461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia.
    Bahceci D; Alpert L; Storozuk T; Liao X; Yozu M; Westerhoff M; Kővári BP; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Oct; 48(10):1326-1334. PubMed ID: 38907614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?
    Puolanne AM; Qadri S; Vesterinen T; Hiltunen S; Mustonen A; Kurki S; Kolho KL; Arola J; Färkkilä M
    Scand J Gastroenterol; 2022 Nov; 57(11):1304-1311. PubMed ID: 35697499
    [No Abstract]   [Full Text] [Related]  

  • 10. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.
    Gupta RB; Harpaz N; Itzkowitz S; Hossain S; Matula S; Kornbluth A; Bodian C; Ullman T
    Gastroenterology; 2007 Oct; 133(4):1099-105; quiz 1340-1. PubMed ID: 17919486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content abnormality frequently develops in the right/proximal colon in patients with primary sclerosing cholangitis and inflammatory bowel disease and is highly predictive of subsequent detection of dysplasia.
    Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2023 Jul; 83(1):116-125. PubMed ID: 37012656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonconventional Dysplasia is Frequently Associated With Goblet Cell Deficient and Serrated Variants of Colonic Adenocarcinoma in Inflammatory Bowel Disease.
    Xiao A; Yozu M; Kővári BP; Yassan L; Liao X; Salomao M; Westerhoff M; Sejben A; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; 48(6):691-698. PubMed ID: 38546105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
    Rubin DT; Huo D; Kinnucan JA; Sedrak MS; McCullom NE; Bunnag AP; Raun-Royer EP; Cohen RD; Hanauer SB; Hart J; Turner JR
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1601-8.e1-4. PubMed ID: 23872237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor Diagnostic Reproducibility in the Identification of Nonconventional Dysplasia in Colitis Impacts the Application of Histologic Stratification Tools.
    Nasreddin N; Jansen M; Loughrey MB; Wang LM; Koelzer VH; Rodriguez-Justo M; Novelli M; Fisher J; Brown MW; Al Bakir I; Hart AL; Dunne P; Graham TA; Leedham SJ
    Mod Pathol; 2024 Mar; 37(3):100419. PubMed ID: 38158125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
    Yvellez OV; Rai V; Sossenheimer PH; Hart J; Turner JR; Weber C; El Jurdi K; Rubin DT
    Inflamm Bowel Dis; 2021 Jan; 27(2):203-206. PubMed ID: 32152624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance.
    Holzmann K; Klump B; Borchard F; Gregor M; Porschen R
    Dis Colon Rectum; 2001 Oct; 44(10):1446-55. PubMed ID: 11598473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of undetected dysplasia found in total colectomy or proctocolectomy specimens of patients with inflammatory bowel disease.
    Bahceci D; Lauwers GY; Choi WT
    Histopathology; 2022 Aug; 81(2):183-191. PubMed ID: 35486500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.